Is fondaparinux effective in the treatment of acute venous thromboembolism (VTE)?

Updated: Jun 05, 2019
  • Author: Kaushal (Kevin) Patel, MD; Chief Editor: Barry E Brenner, MD, PhD, FACEP  more...
  • Print

The combination of two factor Xa inhibitors may be an effective treatment strategy for acute venous thromboembolism (VTE). [117]  In an observational study, 80 of 87 consecutive Japanese patients with VTE who received SC fondaparinux for 7-10 days and then were switched to oral rivaroxaban for 7-14 days had treatment success. Both D-dimer levels and quantitative ultrasound thrombosis (QUT) scores were improved with the use of fondaparinux, and further reductions were achieved using rivaroxaban. [117]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!